{
  "id": 234478,
  "title": "Why the same antibiotic can cure one infection but fail in another",
  "url": "https://urgent.news/2026/08/06/why-the-same-antibiotic-can-cure-one-infection-but-fail-in-another",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T18:20:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-antibiotic-infection.html"
  },
  "original_language": "en",
  "account": "A new study published in Nature Communications has revealed why a common antibiotic, amoxicillin-clavulanic acid, works well for treating urinary tract infections (UTIs) caused by E. coli, but often fails against the same bacteria in other parts of the body. Led by Dr. Vineet Dubey from the University of Liverpool, the research team discovered that some E. coli cells possess hidden resistance mechanisms that allow them to survive antibiotic treatment, even before the drugs are administered. In blood and urine, these resistant bacteria can multiply rapidly, leading to treatment failure. However, when the drug levels in urine are significantly higher than in blood, they eliminate resistant bacteria, including those with pre-existing resistance.\n\nThe study also found that clavulanic acid, which is traditionally considered a helper agent that protects amoxicillin from bacterial defenses, may have its own antibacterial activity when it reaches high concentrations in urine. This additional antibacterial effect may explain why the antibiotic combination is particularly effective for treating UTIs. Dr. Dubey explained, \"Antibiotic resistance is not simply something bacteria either have or do not have. Small resistant subpopulations can exist before treatment begins. Whether those bacteria survive depends greatly on the environment they encounter, including the antibiotic concentrations achieved in different parts of the body.\"\n\nThe findings support current clinical guidance that recommends amoxicillin-clavulanic acid primarily for treating UTIs caused by E. coli. The study also highlights the importance of considering the location of an infection, not just the type of bacteria causing it, when selecting antibiotic treatments. This research points toward new ways of tackling antibiotic resistance (AMR) by understanding how bacteria respond to different environments within the body and finding ways to prevent resistance from emerging. As antimicrobial resistance is considered one of the greatest global health threats of the 21st century, this work could help preserve the effectiveness of existing antibiotics and improve patient care.",
  "summary": "A group of researchers has uncovered why one common antibiotic works for urinary tract infections but often fails elsewhere, offering greater insight into how the body's own chemistry can determine whether antibiotics succeed or fail.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}